203
Views
11
CrossRef citations to date
0
Altmetric
Articles

Hyaluronic acid–conjugated silica nanoparticles for breast cancer therapy

, , &
Pages 777-782 | Received 27 Oct 2015, Accepted 09 Jul 2016, Published online: 19 Aug 2016
 

ABSTRACT

Novel silica nanoparticles (SLN) chemically modified with hyaluronic acid (HA) were developed by exploiting the drug loading property of SLN and the tumor-targeting ability of HA to construct a tumor-targeting paclitaxel (PTX) delivery system (HA-SLN) for potential breast cancer therapy. The experimental results indicated that PTX loading into the HA-SLN was favorable to cancer therapy. PTX-loaded HA-SLN nanoparticles increased the accumulation of PTX in MCF-7 breast cancer cells via CD44 receptor–mediated endocytosis and exhibited superior anticancer activity in vitro. In vivo anticancer efficacy assay revealed that HA-SLN possessed preferable anticancer ability that exhibited minimal toxic side effects of PTX and strong tumor-suppression potential.

Funding

The authors greatly appreciate the financial support from Social Development Research fund in Shaanxi (No. 2009K12-01)

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 674.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.